Yahoo
ASX - Delayed Quote AUD

Sonic Healthcare Limited (SHL.AX)

19.57 +0.50 (+2.62%)
At close: October 30 at 4:10:11 PM GMT+11
Chart Range Bar
Loading chart for SHL.AX
  • Previous Close 19.07
  • Open 19.01
  • Bid 19.56 x --
  • Ask 19.57 x --
  • Day's Range 18.97 - 19.57
  • 52 Week Range 18.11 - 24.27
  • Volume 1,606,033
  • Avg. Volume 2,954,301
  • Market Cap (intraday) 9.672B
  • Beta (5Y Monthly) 0.57
  • PE Ratio (TTM) 15.91
  • EPS (TTM) 1.23
  • Earnings Date Aug 20, 2026
  • Forward Dividend & Yield 1.08 (5.52%)
  • Ex-Dividend Date Sep 2, 2026
  • 1y Target Est 22.12

Sonic Healthcare Limited offers medical diagnostic services, and administrative services and facilities to medical practitioners in Australia, the United States, Germany, and internationally. The company provides laboratory medicine/pathology testing services, such as biochemistry, cytopathology, genetics, haematology, histopathology, immunoserology, microbiology, molecular pathology, prenatal testing, toxicology, and ancillary functions; and radiology services, including magnetic resonance imaging (MRI), computed tomography (CT), ultrasound, X-ray, mammography, nuclear medicine, PET CT, interventional procedures, and bone mineral densitometry (BMD). It also offers primary care medical services comprising general practice clinics, occupational health services, skin cancer clinics, general practice IT solutions, and community-based healthcare services, as well as clinical trials and chronic disease management program services. Sonic Healthcare Limited was incorporated in 1934 and is headquartered in Sydney, Australia.

www.sonichealthcare.com

47,000

Full Time Employees

June 30

Fiscal Year Ends

Healthcare

Sector

Recent News

View More

Performance Overview

Trailing total returns as of 10/30/2026, which may include dividends or other distributions. Benchmark is S&P/ASX 200 [XJO] (^AXJO) .

YTD Return

SHL.AX
8.84%
S&P/ASX 200 [XJO] (^AXJO)
2.22%

1-Year Return

SHL.AX
2.60%
S&P/ASX 200 [XJO] (^AXJO)
0.29%

3-Year Return

SHL.AX
22.33%
S&P/ASX 200 [XJO] (^AXJO)
31.37%

5-Year Return

SHL.AX
40.62%
S&P/ASX 200 [XJO] (^AXJO)
21.63%

Analyst Insights

View More

Analyst Price Targets

19.20
22.12 Average
19.57 Current
27.50 High

Analyst Recommendations

  • Strong Buy
  • Buy
  • Hold
  • Underperform
  • Sell

Statistics

View More

Valuation Measures

Annual
  • Market Cap

  • Enterprise Value

  • Trailing P/E

  • Forward P/E

  • PEG Ratio (current)

  • Price/Sales (ttm)

  • Price/Book (mrq)

  • Enterprise Value/Revenue

  • Enterprise Value/EBITDA

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    5.60%

  • Return on Assets (ttm)

    3.85%

  • Return on Equity (ttm)

    7.50%

  • Revenue (ttm)

    10.87B

  • Net Income Avi to Common (ttm)

    608.29M

  • Diluted EPS (ttm)

    1.23

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    653.69M

  • Total Debt/Equity (mrq)

    68.76%

  • Levered Free Cash Flow (ttm)

    771.36M

Company Insights

Research Reports

View More

People Also Watch

Mobilize your Website
View Site in Mobile | Classic
Share by: